PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.\', \'Centre for Applied Biomedical Research (CRBA), Alma Mater Studiorum, University of Bologna, Bologna, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bcp.14459
?:doi
?:hasPublicationType
?:journal
  • British journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32639062
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.543
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32639062>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32639062>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all